Mobile Diagnostics Without Compromise

The Challenges are Global

Clinicians need critical diagnostics earlier to empower the best, actionable care pathways.

The Value is Real

Empowered clinicians give millions the opportunity of timely treatment and improved patient outcomes.

Our Goal

Is to bring trusted diagnostics to the point of initial patient interaction, to expand access of quality healthcare to new settings, no matter where that patient interaction occurs

Nanomix Goals


Internal Link

Nanōmix Completes Changes to Corporate Name and Ticker Symbol

The Company’s common shares begin trading on the OTC Market under the NNMX ticker symbol as of the opening of the Market today.

Internal Link

Schedule Your Demo at AACC 2021 of the Nanōmix eLab® system.

Critical Host Response Diagnostics in Minutes. Hand-held, Multiplex Immunoassay from a Single Sample.

External Link

Boston Therapeutics Announces $8.4 Million Convertible Placement in Conjunction with Nanōmix Reverse Merger

"We are excited to move forward under this new structure with Nanomix’s complete organization and assets..."